As a type of rare cell, CTC-related studies usually require specific devices, most of which are image-based approaches relying on stained markers such as the FDA-approved CELLSEARCH, which isolates and enumerates the EpCAM+ (epithelial cell adhesion molecule) CTC from leukocytes and other epithelial non-tumor cells [43]. This evidence concerns the gene EPCAM and neoplasm.